Top In Vitro & In Vivo Diagnostic Substances Stocks by Roiver Score™
The 13 In Vitro & In Vivo Diagnostic Substances companies we cover, ranked by the Roiver Score — a transparent 0–100 quality composite. Idexx Laboratories Inc leads with a score of 73.
| # | Company | Market cap | Score |
|---|---|---|---|
| 1 | IDXXIdexx Laboratories Inc | $39.8B | 73Solid |
| 2 | LNTHLantheus Holdings, Inc | $6.5B | 55Solid |
| 3 | QDELQuidelOrtho Corporation Common Stock | $808M | 42Mixed |
| 4 | VNRXVolitionRx Limited | $6M | 40Mixed |
| 5 | MYGNMyriad Genetics Inc | $327M | 25Weak |
| 6 | TKNOAlpha Teknova, Inc. Common Stock | $360M | 20Weak |
| 7 | ICCCImmucell Corp | $89M | 20Weak |
| 8 | ACHVAchieve Life Sciences, Inc. | $726M | 0Weak |
| 9 | NEOGNeogen Corp | $2.6B | 0Weak |
| 10 | BMRABIOMERICA INC | $10M | 0Weak |
| 11 | NTLAIntellia Therapeutics, Inc | $1.6B | 0Weak |
| 12 | CDIOCardio Diagnostics Holdings Inc. Common stock | $6M | 0Weak |
| 13 | CLDXCelldex Therapeutics, Inc | $2.9B | 0Weak |
Track in vitro & in vivo diagnostic substances quality in real time
Follow these names, get weekly AI research digests, and see score changes as they happen.
Start free